CTRI/2019/09/021446
Completed
未知
Clinical validation of iontophoretic delivery of lidocaine as an alternative to EMLA cream
Research Institute and hospital0 sites100 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
- Sponsor
- Research Institute and hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult cancer patients aged 18 years and older coming for IV cannulation
Exclusion Criteria
- •clinical evidence of dehydration, lidocaine allergy, decreased mental status, or patients with pacemaker
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and safety of iontophoresis in patients with age-related cataractAge-related cataractEye DiseasesSenile cataractISRCTN34571027Zhongshan Ophthalmic Center118
Not yet recruiting
Phase 3
Evaluation of iontophoretic effects of kimiainca gel on patients with Knee OsteoarthritisIRCT20220411054495N1Gorgan University of Medical Sciences45
Not yet recruiting
Phase 3
role of injectable platelet rich fibrin in periodontal diseasesCTRI/2023/09/057296TEPARAMESWARI
Completed
Not Applicable
Study of the Safety and Efficacy of an Iontophoretic Device to Treat Recurrent Herpes LabialisISRCTN83097613Klearsen Corporation (USA)13
Active, not recruiting
Not Applicable
Investigation of a low dose Iohexol infusion for the measurement of Glomerular Filtration Rate (GFR) in adult volunteers and patients with Chronic Kidney Disease. - Iohexol infusion as a measure of GFRGlomerular Filtration Rate (GFR). We are comparing a new method of measuring GFR (an Iohexol infusion) with a standard method, recommended by NICE (an Iohexol bolus), in healthy volunteers and patients with Chronic Kidney Disease.EUCTR2010-019933-89-GBSt. George's, University of London35